← Back to Search
Gene Delivery To The Eye Using Adeno-associated Viral Vectors.
Keith R G Martin, R. Klein, H. Quigley
Published 2002 · Biology, Medicine
Download PDFAnalyze on Scholarcy
Adeno-associated virus (AAV) vectors provide a useful way to deliver genes to the eye. They have a number of important properties which make them suitable for this purpose, not least their lack of significant pathogenicity and the potential for long-term transfection of retinal cells. The optimal methods for AAV-mediated gene delivery are determined by the location and characteristics of the target cell type. Efficient gene delivery to photoreceptors and pigment epithelial cells following subretinal injection of AAV has been achieved in various animal models. AAV-mediated gene therapy has been shown to slow photoreceptor loss in rodent models of primary photoreceptor diseases and in dogs with a naturally occurring disease similar to human Leber's congenital amaurosis (LCA). Efficient gene delivery to other cell types such as retinal ganglion cells (RGCs), however, has been more problematic. In this article, we review the potential uses of AAV-mediated gene delivery to the eye. We describe the selection of an appropriate AAV vector for ocular gene transfer studies and discuss the techniques used to deliver the virus to the eye and to assess ocular transfection. We emphasize our techniques for successful gene transfer to retinal ganglion cells, which have often proven challenging to transfect with high efficiency. Using a modified AAV incorporating a chicken beta-actin (CBA) promoter and the woodchuck hepatitis posttranscriptional regulatory element, we describe how our techniques allow approximately 85% of rat retinal ganglion cells to be transfected within 2 weeks of a single intravitreal virus injection. Our techniques facilitate the study of the pathogenesis of RGC diseases such as glaucoma and the development of novel new treatments based on gene therapy.
This paper references
Real-time, noninvasive in vivo assessment of adeno-associated virus-mediated retinal transduction.
J. Bennett (1997)
Influence of promoter and WHV post-transcriptional regulatory element on AAV-mediated transgene expression in the rat brain
J-C Paterna (2000)
Glial cell line derived neurotrophic factor delays photoreceptor degeneration in a transgenic rat model of retinitis pigmentosa.
L. H. McGee Sanftner (2001)
Quantitative comparison of expression with adeno-associated virus (AAV-2) brain-specific gene cassettes
R. Xu (2001)
Quantitative analysis of the packaging capacity of recombinant adeno-associated virus.
J. Dong (1996)
Adeno-associated virus gene transfer to mouse retina.
R. Ali (1998)
Enhanced expression of transgenes from adeno-associated virus vectors with the woodchuck hepatitis virus posttranscriptional regulatory element: implications for gene therapy.
J. E. Loeb (1999)
Rescue of photoreceptor function by AAV-mediated gene transfer in a mouse model of inherited retinal degeneration
C. Jomary (1997)
Retinal glutamate transporter changes in experimental glaucoma and after optic nerve transection in the rat.
Keith R G Martin (2002)
Persistent transgene product in retina, optic nerve and brain after intraocular injection of rAAV
L. Dudus (1999)
AAV-mediated delivery of ciliary neurotrophic factor prolongs photoreceptor survival in the rhodopsin knockout mouse.
F. Liang (2001)
Reporter expression persists 1 year after adeno-associated virus-mediated gene transfer to the optic nerve.
J. Guy (1999)
Dose and Promoter Effects of Adeno-Associated Viral Vector for Green Fluorescent Protein Expression in the Rat Brain
R. Klein (2002)
Evaluation of recombinant adeno-associated virus as a gene transfer vector for the retina.
C. Grant (1997)
Additional transduction events after subretinal readministration of recombinant adeno-associated virus.
V. Anand (2000)
Cross-Packaging of a Single Adeno-Associated Virus (AAV) Type 2 Vector Genome into Multiple AAV Serotypes Enables Transduction with Broad Specificity
J. Rabinowitz (2002)
Number of people with glaucoma worldwide.
H. Quigley (1996)
Gene therapy restores vision in a canine model of childhood blindness
G. Acland (2001)
Prolonged delivery of brain-derived neurotrophic factor by adenovirus-infected Müller cells temporarily rescues injured retinal ganglion cells.
A. Di Polo (1998)
Kinetics of transgene expression in mouse retina following sub-retinal injection of recombinant adeno-associated virus
G. Sarra (2002)
Neuron-Specific Transduction in the Rat Septohippocampal or Nigrostriatal Pathway by Recombinant Adeno-associated Virus Vectors
R. Klein (1998)
Woodchuck Hepatitis Virus Contains a Tripartite Posttranscriptional Regulatory Element
J. Donello (1998)
A generic intron increases gene expression in transgenic mice.
T. Choi (1991)
Evaluation of adeno-associated virus-mediated gene transfer into the rat retina by clinical fluorescence photography.
F. Rolling (1999)
Adeno-associated virus vectors: activity and applications in the CNS
A. Peel (2000)
Gene replacement therapy in the retinal degeneration slow (rds) mouse: the effect on retinal degeneration following partial transduction of the retina.
G. Sarra (2001)
Restoration of photoreceptor ultrastructure and function in retinal degeneration slow mice by gene therapy
R. Ali (2000)
Use of Green Fluorescent Protein in mouse embryos.
M. Zernicka-Goetz (2001)
Long-term protection of retinal structure but not function using RAAV.CNTF in animal models of retinitis pigmentosa.
F. Liang (2001)
Retinal degeneration is slowed in transgenic rats by AAV-mediated delivery of FGF-2.
D. Lau (2000)
Stable transgene expression in rod photoreceptors after recombinant adeno-associated virus-mediated gene transfer to monkey retina.
J. Bennett (1999)
Adeno-associated virus-mediated gene transfer into human retinal pigment epithelium cells.
Y. Lai (1998)
Translimbal laser photocoagulation to the trabecular meshwork as a model of glaucoma in rats.
H. Levkovitch-Verbin (2002)
Gene transfer into the mouse retina mediated by an adeno-associated viral vector.
R. Ali (1996)
Adeno-associated and Herpes Simplex Viruses as Vectors for Gene Transfer to the Corneal Endothelium
T. Hudde (2000)
The packaging capacity of adeno‐associated virus (AAV) and the potential for wild‐type‐plus AAV gene therapy vectors
P. Hermonat (1997)
Epitope-tagged recombinant AAV vectors for expressing neurturin and its receptor in retinal cells.
C. Jomary (2001)
Efficient photoreceptor-targeted gene expression in vivo by recombinant adeno-associated virus.
J. Flannery (1997)
Long‐term real‐time monitoring of adeno‐associated virus‐mediated gene expression in the rat retina
F. Rolling (2000)
Novel tools for production and purification of recombinant adenoassociated virus vectors.
D. Grimm (1998)
This paper is referenced by
Extracellular signal‐regulated kinase 1/2 mediates survival, but not axon regeneration, of adult injured central nervous system neurons in vivo
V. Pernet (2005)
[Gene therapy: nucleic acids as drugs. Action mechanisms and delivery into the cell].
B. Cavagnari (2011)
Counteracting the Nogo Receptor Enhances Optic Nerve Regeneration If Retinal Ganglion Cells Are in an Active Growth State
D. Fischer (2004)
In vitro analysis of promoter activity in Müller cells
S. F. Geller (2008)
Photogenetic Retinal Prosthesis
N. Grossman (2010)
DNA as Therapeutics; an Update
P. Saraswat (2009)
AAV-Based Targeting Gene Therapy
Wenfang Shi (2008)
Patterned Optical Activation of Retinal Ganglion Cells
N. Farah (2007)
The expression of netrin-1 in the intact and injured adult mice retina
Pegah Chehrazi (2017)
STUDY OF DNA CONDENSATION FOR APPLICATIONS IN NUCLEOSOME INTERACTIONS AND GENE DELIVERY WITH NOVEL PEPTIDE VEHICLES
Dandan Huang (2009)
Recent advances in retinal degeneration
R. Anderson (2008)
Photoreceptor protection by iris pigment epithelial transplantation transduced with AAV-mediated brain-derived neurotrophic factor gene.
M. Hojo (2004)
Modification of adenovirus capsid proteins for gene therapy applications
Yizhe Tang (2009)
Adenosine kinase as a target for therapeutic antisense strategies in epilepsy
Panos Theofilas (2011)
Applications of nanoparticles in ophthalmology
Y. Diebold (2010)
Viral and Non-viral Vectors in Gene Therapy: Technology Development and Clinical Trials
K. Lundstrom (2003)
Viral vectors: a wide range of choices and high levels of service.
P. Osten (2007)
Immunotherapy of Uveitis: is Gene Therapy in our Future?
R. Caspi (2007)
Changes in adeno-associated virus-mediated gene delivery in retinal degeneration.
K. D. Kolstad (2010)
Nanoparticle-based technologies for retinal gene therapy.
J. Adijanto (2015)
Gene therapy for optic nerve disease
K. Martin (2004)
Widespread dispersion of adeno-associated virus serotype 1 and adeno-associated virus serotype 6 vectors in the rat central nervous system and in human glioblastoma multiforme xenografts.
P. C. Huszthy (2005)
DNA-based therapeutics and DNA delivery systems: A comprehensive review
S. Patil (2008)
From Nucleic Acids Sequences to Molecular Medicine
V. Erdmann (2012)
In Vivo Evaluation of PAX6 Overexpression and NMDA Cytotoxicity to Stimulate Proliferation in the Mouse Retina
Ehsan Ranaei Pirmardan (2018)
AAV vectors for retinal gene therapy
Seok-Hong Min (2005)
Rewiring the injured CNS: Lessons from the optic nerve
L. Benowitz (2008)
Baculovirus is an efficient vector for the transduction of the eye: comparison of baculovirus‐ and adenovirus‐mediated intravitreal vascular endothelial growth factor D gene transfer in the rabbit eye
K. Kinnunen (2009)
Synthesis of polymer nanoparticles sensitive to pH for DNA delivery in intracellular environment
Eduardo Lopes (2011)
AAV-mediated transfer of RhoA shRNA and CNTF promotes retinal ganglion cell survival and axon regeneration
Ling-Ping Cen (2017)
64 – Gene Therapy in Glaucoma
Stuart J. Mckinnon (2015)
Effect of GDNF gene transfer into axotomized retinal ganglion cells using in vivo electroporation with a contact lens-type electrode
H. Ishikawa (2005)See more